Industry: Chemical & Material
Published Date: 2024-01-17
Pages: 94 Pages
Report ld: 2270651
Request Sample
Customized Report
Vinpocetine API Market Size(US$)

CAGR 2024-2030
5.6%
Market Size,2030
USD 149.8
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Vinpocetine API (Active Pharmaceutical Ingredient) is a synthetic compound derived from the natural alkaloid vincamine, which is found in the periwinkle plant. Vinpocetine is created by modifying vincamine to enhance its bioavailability and therapeutic effects. It is primarily used as a nootropic agent and cerebral vasodilator, meaning it improves blood flow to the brain. Vinpocetine has shown potential in enhancing cognitive function, memory, and concentration. It also exhibits neuroprotective properties by reducing oxidative stress and inflammation in the brain. As a result, Vinpocetine API is commonly used in pharmaceutical formulations and dietary supplements targeting cognitive health and related neurological disorders.
The global Vinpocetine API market was valued at US$ 103 million in 2023 and is anticipated to reach US$ 149.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The industry trend of Vinpocetine API has witnessed steady growth and widespread use in the pharmaceutical and nutraceutical sectors. With an aging population and increasing interest in cognitive enhancement, there has been a rising demand for products and medicines that support brain health. Vinpocetine, with its established cognitive benefits and neuroprotective properties, has attracted attention from manufacturers and researchers alike. The market for Vinpocetine API is expected to continue expanding as new formulations and delivery methods are developed. Additionally, a growing consumer focus on overall well-being and cognitive performance fuels the demand for Vinpocetine-containing products, reinforcing its positive industry trend.
This report aims to provide a comprehensive presentation of the global market for Vinpocetine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vinpocetine API.
MARKET SEGMENTATION
REPORT SCOPE
The Vinpocetine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vinpocetine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vinpocetine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vinpocetine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Vinpocetine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Vinpocetine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Vinpocetine API Market Overview
1.1 Product Definition
1.2 Vinpocetine API Segment by Type
1.2.1 Global Vinpocetine API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 99% Content
1.2.3 Other Content
1.3 Vinpocetine API Segment by Application
1.3.1 Global Vinpocetine API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Research
1.4 Global Market Growth Prospects
1.4.1 Global Vinpocetine API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Vinpocetine API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Vinpocetine API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Vinpocetine API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Vinpocetine API Production Market Share by Manufacturers (2019-2024)
2.2 Global Vinpocetine API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Vinpocetine API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Vinpocetine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Vinpocetine API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Vinpocetine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Vinpocetine API, Product Offered and Application
2.8 Global Key Manufacturers of Vinpocetine API, Date of Enter into This Industry
2.9 Vinpocetine API Market Competitive Situation and Trends
2.9.1 Vinpocetine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Vinpocetine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Vinpocetine API Production by Region
3.1 Global Vinpocetine API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Vinpocetine API Production Value by Region (2019-2030)
3.2.1 Global Vinpocetine API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Vinpocetine API by Region (2025-2030)
3.3 Global Vinpocetine API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Vinpocetine API Production by Region (2019-2030)
3.4.1 Global Vinpocetine API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Vinpocetine API by Region (2025-2030)
3.5 Global Vinpocetine API Market Price Analysis by Region (2019-2024)
3.6 Global Vinpocetine API Production and Value, Year-over-Year Growth
3.6.1 North America Vinpocetine API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Vinpocetine API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Vinpocetine API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Vinpocetine API Production Value Estimates and Forecasts (2019-2030)
4 Vinpocetine API Consumption by Region
4.1 Global Vinpocetine API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Vinpocetine API Consumption by Region (2019-2030)
4.2.1 Global Vinpocetine API Consumption by Region (2019-2024)
4.2.2 Global Vinpocetine API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Vinpocetine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Vinpocetine API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Vinpocetine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Vinpocetine API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Vinpocetine API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Vinpocetine API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Vinpocetine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Vinpocetine API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Vinpocetine API Production by Type (2019-2030)
5.1.1 Global Vinpocetine API Production by Type (2019-2024)
5.1.2 Global Vinpocetine API Production by Type (2025-2030)
5.1.3 Global Vinpocetine API Production Market Share by Type (2019-2030)
5.2 Global Vinpocetine API Production Value by Type (2019-2030)
5.2.1 Global Vinpocetine API Production Value by Type (2019-2024)
5.2.2 Global Vinpocetine API Production Value by Type (2025-2030)
5.2.3 Global Vinpocetine API Production Value Market Share by Type (2019-2030)
5.3 Global Vinpocetine API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Vinpocetine API Production by Application (2019-2030)
6.1.1 Global Vinpocetine API Production by Application (2019-2024)
6.1.2 Global Vinpocetine API Production by Application (2025-2030)
6.1.3 Global Vinpocetine API Production Market Share by Application (2019-2030)
6.2 Global Vinpocetine API Production Value by Application (2019-2030)
6.2.1 Global Vinpocetine API Production Value by Application (2019-2024)
6.2.2 Global Vinpocetine API Production Value by Application (2025-2030)
6.2.3 Global Vinpocetine API Production Value Market Share by Application (2019-2030)
6.3 Global Vinpocetine API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 COVEX SA
7.1.1 COVEX SA Vinpocetine API Corporation Information
7.1.2 COVEX SA Vinpocetine API Product Portfolio
7.1.3 COVEX SA Vinpocetine API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 COVEX SA Main Business and Markets Served
7.1.5 COVEX SA Recent Developments/Updates
7.2 Xiamen Sun Tree
7.2.1 Xiamen Sun Tree Vinpocetine API Corporation Information
7.2.2 Xiamen Sun Tree Vinpocetine API Product Portfolio
7.2.3 Xiamen Sun Tree Vinpocetine API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Xiamen Sun Tree Main Business and Markets Served
7.2.5 Xiamen Sun Tree Recent Developments/Updates
7.3 Shanxi Yongjin Group
7.3.1 Shanxi Yongjin Group Vinpocetine API Corporation Information
7.3.2 Shanxi Yongjin Group Vinpocetine API Product Portfolio
7.3.3 Shanxi Yongjin Group Vinpocetine API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Shanxi Yongjin Group Main Business and Markets Served
7.3.5 Shanxi Yongjin Group Recent Developments/Updates
7.4 Northeast Pharma
7.4.1 Northeast Pharma Vinpocetine API Corporation Information
7.4.2 Northeast Pharma Vinpocetine API Product Portfolio
7.4.3 Northeast Pharma Vinpocetine API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Northeast Pharma Main Business and Markets Served
7.4.5 Northeast Pharma Recent Developments/Updates
7.5 Zhang Jiagang Vinsce Bio-pharm
7.5.1 Zhang Jiagang Vinsce Bio-pharm Vinpocetine API Corporation Information
7.5.2 Zhang Jiagang Vinsce Bio-pharm Vinpocetine API Product Portfolio
7.5.3 Zhang Jiagang Vinsce Bio-pharm Vinpocetine API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Zhang Jiagang Vinsce Bio-pharm Main Business and Markets Served
7.5.5 Zhang Jiagang Vinsce Bio-pharm Recent Developments/Updates
7.6 Jiangsu Swellxin
7.6.1 Jiangsu Swellxin Vinpocetine API Corporation Information
7.6.2 Jiangsu Swellxin Vinpocetine API Product Portfolio
7.6.3 Jiangsu Swellxin Vinpocetine API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Jiangsu Swellxin Main Business and Markets Served
7.6.5 Jiangsu Swellxin Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Vinpocetine API Industry Chain Analysis
8.2 Vinpocetine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Vinpocetine API Production Mode & Process
8.4 Vinpocetine API Sales and Marketing
8.4.1 Vinpocetine API Sales Channels
8.4.2 Vinpocetine API Distributors
8.5 Vinpocetine API Customers
9 Vinpocetine API Market Dynamics
9.1 Vinpocetine API Industry Trends
9.2 Vinpocetine API Market Drivers
9.3 Vinpocetine API Market Challenges
9.4 Vinpocetine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Vinpocetine API was estimated to be worth US$ 119 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
The global Vinpocetine API market was valued at US$ 119 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 134
USD 2900.00
(Single User License)
The global Vinpocetine API market size was US$ 113 million in 2024 and is forecast to a readjusted size of US$ 165 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Vinpocetine API market is projected to grow from US$ 113 million in 2024 to US$ 165 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 146
USD 4900.00
(Single User License)
The global market for Vinpocetine API was valued at US$ 113 million in the year 2024 and is projected to reach a revised size of US$ 165 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published Date: 2025-01-16
Pages: 92
USD 2900.00
(Single User License)
The global market for Vinpocetine API was estimated to be worth US$ 113 million in 2024 and is forecast to a readjusted size of US$ 165 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)
Vinpocetine API (Active Pharmaceutical Ingredient) is a synthetic compound derived from the natural alkaloid vincamine, which is found in the periwinkle plant. Vinpocetine is created by modifying vincamine to enhance its bioavailability and therapeutic effects. It is primarily used as a nootropic agent and cerebral vasodilator, meaning it improves blood flow to the brain. Vinpocetine has shown potential in enhancing cognitive function, memory, and concentration. It also exhibits neuroprotective properties by reducing oxidative stress and inflammation in the brain. As a result, Vinpocetine API is commonly used in pharmaceutical formulations and dietary supplements targeting cognitive health and related neurological disorders.
Published Date: 2024-04-12
Pages: 92
USD 4900.00
(Single User License)
Vinpocetine API (Active Pharmaceutical Ingredient) is a synthetic compound derived from the natural alkaloid vincamine, which is found in the periwinkle plant. Vinpocetine is created by modifying vincamine to enhance its bioavailability and therapeutic effects. It is primarily used as a nootropic agent and cerebral vasodilator, meaning it improves blood flow to the brain. Vinpocetine has shown potential in enhancing cognitive function, memory, and concentration. It also exhibits neuroprotective properties by reducing oxidative stress and inflammation in the brain. As a result, Vinpocetine API is commonly used in pharmaceutical formulations and dietary supplements targeting cognitive health and related neurological disorders.
Published Date: 2024-01-10
Pages: 100
USD 3950.00
(Single User License)
The global market for Vinpocetine API was estimated to be worth US$ 119 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
The global Vinpocetine API market was valued at US$ 119 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-04-18
Pages: 134
The global Vinpocetine API market size was US$ 113 million in 2024 and is forecast to a readjusted size of US$ 165 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Vinpocetine API market is projected to grow from US$ 113 million in 2024 to US$ 165 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 146
The global market for Vinpocetine API was valued at US$ 113 million in the year 2024 and is projected to reach a revised size of US$ 165 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-01-16
Pages: 92
The global market for Vinpocetine API was estimated to be worth US$ 113 million in 2024 and is forecast to a readjusted size of US$ 165 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
Vinpocetine API (Active Pharmaceutical Ingredient) is a synthetic compound derived from the natural alkaloid vincamine, which is found in the periwinkle plant. Vinpocetine is created by modifying vincamine to enhance its bioavailability and therapeutic effects. It is primarily used as a nootropic agent and cerebral vasodilator, meaning it improves blood flow to the brain. Vinpocetine has shown potential in enhancing cognitive function, memory, and concentration. It also exhibits neuroprotective properties by reducing oxidative stress and inflammation in the brain. As a result, Vinpocetine API is commonly used in pharmaceutical formulations and dietary supplements targeting cognitive health and related neurological disorders.
Published: 2024-04-12
Pages: 92
Vinpocetine API (Active Pharmaceutical Ingredient) is a synthetic compound derived from the natural alkaloid vincamine, which is found in the periwinkle plant. Vinpocetine is created by modifying vincamine to enhance its bioavailability and therapeutic effects. It is primarily used as a nootropic agent and cerebral vasodilator, meaning it improves blood flow to the brain. Vinpocetine has shown potential in enhancing cognitive function, memory, and concentration. It also exhibits neuroprotective properties by reducing oxidative stress and inflammation in the brain. As a result, Vinpocetine API is commonly used in pharmaceutical formulations and dietary supplements targeting cognitive health and related neurological disorders.
Published: 2024-01-10
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now